Glycogen storage disease due to acid maltase deficiency (Q84784): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1427054474 / rank
 
Normal rank

Revision as of 10:08, 15 August 2026

Glycogen storage disease type 2 (GSD II), or Pompe disease, is a lysosomal storage disease which particularly affects the skeletal and respiratory muscles with varying degrees of gravity and which, in the infantile form, is associated with hypertrophic cardiomyopathy. The infantile form of the disease starts before the age of 3 months with major hypotonia, sucking and swallowing difficulties, hypertrophic cardiomyopathy and progressive hepatomegaly. The adult form results in progressive limb-girdle myopathy beginning with the lower limbs, and affects the respiratory system. A large spectrum of intermediate forms exists between these two extremes.
Language Label Description Also known as
default for all languages
ID_1427054474
    English
    Glycogen storage disease due to acid maltase deficiency
    Glycogen storage disease type 2 (GSD II), or Pompe disease, is a lysosomal storage disease which particularly affects the skeletal and respiratory muscles with varying degrees of gravity and which, in the infantile form, is associated with hypertrophic cardiomyopathy. The infantile form of the disease starts before the age of 3 months with major hypotonia, sucking and swallowing difficulties, hypertrophic cardiomyopathy and progressive hepatomegaly. The adult form results in progressive limb-girdle myopathy beginning with the lower limbs, and affects the respiratory system. A large spectrum of intermediate forms exists between these two extremes.

      Statements